Bioavailability of nanomaterials:bridging the gap between nanostructures and their bioactivity  

作　　者：Mingjing Cao Chunying Chen 

机构地区：[1]CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,China [2]University of Chinese Academy of Sciences,China [3]The GBA National Institute for Nanotechnology Innovation,China

出　　处：《National Science Review》2022年第10期53-56,共4页国家科学评论（英文版）

基　　金：the Ministry of Science and Technology of China(2021YFA1200900);the Major Instrument Project of the National Natural Science Foundation of China(22027810);the National Postdoctoral Program for Innovative Talents(BX2021088);the Project funded by the China Postdoctoral Science Foundation(2021M700977).

摘　　要：Nanomaterials(NMs)have enormous potential as nanomedicines for diagnosing and fighting various diseases.Researchers make every endeavor to design diverse nanomedicines with novel nanostructures and smart payloads.But how stable are nanomedicines before and after exerting their functions at target sites?What can we do to maximize the efficiency of nanomedicines?

关 键 词：FIGHTING BRIDGING PAYLOAD 

分 类 号：TQ460.1[化学工程—制药化工] TB383.1[一般工业技术—材料科学与工程]